Skip to main content

Advanced Search

Projected result for your current search:: 0

Search Operators:

You can use operators in your search query to narrow down your results even more. Click on the search operator to see an explanation of how it works.
Finds documents with exactly this word group, in exactly this word order and spelling (e.g. "employer branding").
Finds documents with both search terms (e.g. sales AND bonus).
Finds documents with one or the other search term (e.g. porsche OR volkswagen).
Finds documents with all search terms. Blank space is understood as AND (e.g. man robot production).
Finds documents with no appearance of the word behind NOT (e.g. ford NOT "harrison ford").
Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g. COUNT(gear)>8).
Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g. NEAR(recruit, professionals, 20)).
Finds documents with the search term in word versions or composites. The asterisk * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g. lightweight*, *lightweight, *lightweight*).
Finds documents with the search term in different spellings. "?" allows only one character (e.g. organi?ation).
Special characters are understood as AND (e.g. Miller Bros. & Sons).
 Log in
Top

Drugs

Issue 2/2014

Content (9 Articles)

Responsiveness to Erythropoiesis-Stimulating Agents in Chronic Kidney Disease: Does Geography Matter?

  • Current Opinion

Luca De Nicola, Francesco Locatelli, Giuseppe Conte, Roberto Minutolo

Does Treatment of Psoriasis Reduce the Risk of Cardiovascular Disease?

  • Leading Article

Sarah Churton, Liza Brown, Thuzar M. Shin, Neil J. Korman

Acute Hyperglycemia Associated with Short-Term Use of Atypical Antipsychotic Medications

  • Review Article

T. Vivian Liao, Stephanie V. Phan

Cobicistat: A Review of Its Use as a Pharmacokinetic Enhancer of Atazanavir and Darunavir in Patients with HIV-1 Infection

  • Adis Drug Evaluation

Emma D. Deeks

Afatinib: A Review of Its Use in the Treatment of Advanced Non-Small Cell Lung Cancer

  • Adis Drug Evaluation

Gillian M. Keating

Sitagliptin: A Review of Its Use in Patients with Type 2 Diabetes Mellitus

  • Adis Drug Evaluation

Greg L. Plosker

Rivaroxaban: A Review of Its Use in the Treatment of Deep Vein Thrombosis or Pulmonary Embolism and the Prevention of Recurrent Venous Thromboembolism

  • Adis Drug Evaluation

Celeste B. Burness, Caroline M. Perry

Ibrutinib: First Global Approval

  • R&D Insight Report

Fiona Cameron, Mark Sanford

Sofosbuvir: First Global Approval

  • R&D Insight Report

Gillian M. Keating, Asha Vaidya

Jan 14
Issue: 1/2014
Mar 14
Issue: 3/2014

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images